Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33789008

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Apr 1
First author
Kelly RJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2021 Apr 1;384(13):1269-1271. doi: 10.1056/NEJMe2101983.
    note
    Source null
    related pmid
    33789017
    relationship
    Comment in
  2. citation
    Signal Transduct Target Ther. 2021 Aug 23;6(1):314. doi: 10.1038/s41392-021-00722-0.
    note
    Source null
    related pmid
    34426572
    relationship
    Comment in
  3. citation
    Strahlenther Onkol. 2021 Nov;197(11):1040-1042. doi: 10.1007/s00066-021-01849-3.
    note
    Source null
    related pmid
    34515819
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):5-10. doi: 10.1016/j.ijrobp.2021.12.177.
    note
    Source null
    related pmid
    35427559
    relationship
    Comment in
  5. citation
    N Engl J Med. 2023 Feb 16;388(7):672. doi: 10.1056/NEJMx220014.
    note
    Source null
    related pmid
    36791183
    relationship
    Erratum in

Authors and identifiers

  1. name
    Kelly RJ
    type
    Author
  2. name
    Ajani JA
    type
    Author
  3. name
    Kuzdzal J
    type
    Author
  4. name
    Zander T
    type
    Author
  5. name
    Van Cutsem E
    type
    Author
  6. name
    Piessen G
    type
    Author
  7. name
    Mendez G
    type
    Author
  8. name
    Feliciano J
    type
    Author
  9. name
    Motoyama S
    type
    Author
  10. name
    Lièvre A
    type
    Author
  11. name
    Uronis H
    type
    Author
  12. name
    Elimova E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kelly RJ
    type
    Author
  2. name
    Ajani JA
    type
    Author
  3. name
    Kuzdzal J
    type
    Author
  4. name
    Zander T
    type
    Author
  5. name
    Van Cutsem E
    type
    Author
  6. name
    Piessen G
    type
    Author
  7. name
    Mendez G
    type
    Author
  8. name
    Feliciano J
    type
    Author
  9. name
    Motoyama S
    type
    Author
  10. name
    Lièvre A
    type
    Author
  11. name
    Uronis H
    type
    Author
  12. name
    Elimova E
    type
    Author
bibliography ids
  1. nci-bib-b0eeed5096aa8e6e06e7871c
book metadata
content sha256
cc9f97e78853839443c9f61c94ea65788c870125accb04b2ccff7401a01e2d55
document type
citation
dois
  1. 10.1056/NEJMoa2032125
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33789008
immutable id
pubmed:33789008@cc9f97e78853839443c9f61c94ea65788c870125accb04b2ccff7401a01e2d55
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
13
name
The New England journal of medicine
nlm unique id
0255562
pages
1191-1203
volume
384
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2021 Apr 1;384(13):1269-1271. doi: 10.1056/NEJMe2101983.
    note
    Source null
    related pmid
    33789017
    relationship
    Comment in
  2. citation
    Signal Transduct Target Ther. 2021 Aug 23;6(1):314. doi: 10.1038/s41392-021-00722-0.
    note
    Source null
    related pmid
    34426572
    relationship
    Comment in
  3. citation
    Strahlenther Onkol. 2021 Nov;197(11):1040-1042. doi: 10.1007/s00066-021-01849-3.
    note
    Source null
    related pmid
    34515819
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):5-10. doi: 10.1016/j.ijrobp.2021.12.177.
    note
    Source null
    related pmid
    35427559
    relationship
    Comment in
  5. citation
    N Engl J Med. 2023 Feb 16;388(7):672. doi: 10.1056/NEJMx220014.
    note
    Source null
    related pmid
    36791183
    relationship
    Erratum in
outcomes validated
false
pmid
33789008
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
c5763fa80f30ecb20c3d07d4bf7002ec38278488558240bdf1eb489200307e25
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Apr 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33789008/
title
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

Preserved source evidence · Not medical advice